Free NewsletterPro Login

From Lawsuit to Partnership in One Month. HIMS Stock Is Up 40%.

A stylized illustration of a cylindrical cup with blue arrows and lines indicating a swirling or rotational motion inside the cup.
Published Mar 9, 2026
Share:
A green upward graph divides a stormy courthouse lawsuit scene with legal symbols on the left from a bright financial partnership with gold and coins on the right, symbolizing HIMS stock potential. An hourglass marks time in the center.
Summary:

  • Novo Nordisk dropped its patent lawsuit against Hims & Hers after the two struck a new deal.
  • Hims will now sell branded Ozempic and Wegovy on its platform — and stop marketing knockoffs.
  • HIMS shares jumped 41% Monday; the stock was still down 62% from its 52-week high going in.

A month ago, Novo Nordisk was suing Hims & Hers. Monday, they announced a partnership.

How We Got Here

Hims built a significant chunk of its business selling compounded semaglutide — essentially a cheaper, copycat version of Ozempic and Wegovy — while Novo's drugs were on the FDA's shortage list. When the FDA declared the shortage over in February 2025, the legal ground shifted. The two companies tried a partnership last year; Novo walked away when Hims kept selling compounded versions anyway. Then in February, Novo sued Hims after the telehealth company launched a $49 knockoff of the Wegovy pill — and pulled it two days later under regulatory pressure. The FDA threatened "decisive steps" and flagged Hims to the DOJ.

What the Deal Actually Says

Under the new agreement, Hims will offer branded Ozempic and Wegovy injections and pills on its platform later this month — at the same price as other telehealth providers. In exchange, Hims stops advertising compounded GLP-1 drugs and limits them to cases where a licensed provider determines they're medically necessary. Novo dropped the lawsuit, though it reserved the right to refile. FDA Commissioner Marty Makary endorsed the deal on X Monday, calling it a win for affordability.

The trade-off: Hims loses its low-cost compounding edge but gains a legitimate, scalable product line — and removes the biggest legal overhang on its stock.

What Investors Are Watching Now

HIMS jumped 41% Monday; NVO gained 3%. Needham raised its price target to $30, Citi to $24. Even after the pop, HIMS trades at roughly 20 times forward earnings with revenue still growing 28% quarter over quarter. The stock was down 62% from its 52-week high going into Monday.

The bigger question: Eli Lilly's weight-loss pill, orforglipron, could hit the market as early as Q2. More competition means Hims' new partnership with Novo may face pressure before it even finds its footing.

Disclosure

Get Market Briefs delivered to your inbox every morning for free!

No fluff. No noise. No politics. Just finance news you can read in 5 minutes.

Blogs

April 15, 2026
What Is a Put Option? A Simple Guide for Investors
  • A put option is a contract that gives you the right to sell a stock at a set price before a set date.
  • Investors use put options to protect their portfolio against losses or to profit when they think a stock will drop.
  • The most you can lose when buying a put option is the premium you paid for the contract.
Read More
April 13, 2026
What Is Free Cash Flow? How To Find It & Why It's Important
  • Free cash flow is the cash a company has left after paying its bills and putting money back into the business.
  • Investors use free cash flow to figure out what a company is really worth - and if the stock is a good deal.
  • You can find free cash flow on a company's cash flow report, one of three key reports every public company files.
Read More
April 13, 2026
Non Taxable Income: What It Is and Why Investors Care

Non taxable income is money you earn that the IRS does not tax - like Roth IRA cash, muni bond interest, and certain investment gains. The U.S. tax code taxes workers, investors, and business owners at very different rates. Tools like Roth accounts, muni bonds, and real estate write-offs can help you keep more of what you earn.

Read More
April 11, 2026
Nasdaq Index Fund: A Beginner's Guide to Investing in the Nasdaq 100
  • A Nasdaq index fund lets you invest in the 100 biggest non-bank companies on the stock market all at once.
  • You can access the Nasdaq through index funds, mutual funds, or ETFs like QQQ - each with its own fees, trading rules, and style.
  • Picking the right Nasdaq index fund comes down to three things: who runs it, what is in it, and what it costs.
Read More
April 11, 2026
What Is Wealth? It's Not What Most People Think
  • Wealth is about owning assets that grow and pay you - not just earning a high salary.
  • In a capitalist system, there are two ways to get paid: from your labor and from your capital.
  • Building wealth takes a shift in mindset, a money system, and the habit of investing before you spend.
Read More
April 10, 2026
Micron Stock: The AI Memory Play Most Investors Are Missing
  • Micron (MU) is the only U.S. company that makes HBM chips - the short-term memory layer that AI systems need to run.
  • By early 2026, data centers were using about 70% of all memory chips made in the world, creating an 18-month backlog for new orders.
  • Micron's DRAM - or short-term memory chip - revenue jumped 69% year over year, and the company shifted away from consumer products to focus almost entirely on AI.
Read More
April 10, 2026
What Is Working Capital? What Investors Need To Know
  • Working capital is current assets minus current liabilities - it shows if a business can pay its short-term bills.
  • You find it on a company's balance sheet inside its 10-K report.
  • Changes in working capital show up on the cash flow statement and affect how much cash a business really makes.
Read More
April 9, 2026
What Is a Meme Stock? A Simple Guide for New Investors

You've probably heard the term "meme stock" thrown around on […]

Read More
April 9, 2026
Enterprise Value Formula: What It Is and How to Calculate It
  • Enterprise value (EV) shows what a company is really worth - debt and cash included - not just its stock price
  • The enterprise value formula is: Market Cap + Total Debt - Cash and Cash Equivalents
  • Investors use EV with metrics like EBITDA to compare stocks more fairly than market cap alone
Read More
April 8, 2026
Return on Equity: What It Is and How to Use It
  • Return on equity (ROE) measures how much profit a company earns for every dollar of shareholder equity
  • The formula is simple: net income divided by shareholder equity
  • A higher ROE can signal a company that is good at turning investor money into profit - but it is not the full picture
Read More
1 2 3 17
Share via
Copy link